Effectiveness and Safety of Valsartan in Children Aged 6 to 16 Years With Hypertension
The effectiveness and safety of valsartan have not been assessed in hypertensive children. Therefore, hypertensive patients aged 6 to 16 years (n=261) were randomized to receive weight‐stratified low‐ (10/20 mg), medium‐ (40/80 mg), or high‐dose (80/160 mg) valsartan for 2 weeks. After 2 weeks, pati...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2011
|
| 在线阅读: | https://doi.org/10.1111/j.1751-7176.2011.00432.x |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|